Sarepta Therapeutics Inc (SRPT)
Receivables turnover
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Revenue | US$ in thousands | 1,901,980 | 1,243,340 | 933,013 | 701,887 | 540,099 |
| Receivables | US$ in thousands | — | — | — | — | — |
| Receivables turnover | — | — | — | — | — |
December 31, 2024 calculation
Receivables turnover = Revenue ÷ Receivables
= $1,901,980K ÷ $—K
= —
Based on the provided data, Sarepta Therapeutics Inc's receivables turnover ratio is not available for the years 2020 through 2024. This lack of information hinders a thorough analysis of the company's efficiency in collecting receivables during these periods. Receivables turnover is a key metric for assessing how efficiently a company is managing its accounts receivable, as a higher turnover ratio typically indicates a more effective and timely collection of outstanding payments from customers. Without specific values for the receivables turnover ratio, it is challenging to evaluate Sarepta Therapeutics Inc's performance in this aspect over the specified years.
Peer comparison
Dec 31, 2024